IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Return 17.25%
This Quarter Return
+2.7%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$415M
AUM Growth
+$35.8M
Cap. Flow
+$33.4M
Cap. Flow %
8.06%
Top 10 Hldgs %
52.35%
Holding
76
New
10
Increased
22
Reduced
9
Closed
8

Top Buys

1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$14.4M
2
AMGN icon
Amgen
AMGN
$14.3M
3
ILMN icon
Illumina
ILMN
$10.9M
4
INCY icon
Incyte
INCY
$9.18M
5
TVTX icon
Travere Therapeutics
TVTX
$8.73M

Top Sells

1
REGN icon
Regeneron Pharmaceuticals
REGN
$17.8M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
$14M
3
UTHR icon
United Therapeutics
UTHR
$7.77M
4
XLRN
Acceleron Pharma Inc.
XLRN
$7.59M
5
PTGX icon
Protagonist Therapeutics
PTGX
$6.81M

Sector Composition

1 Healthcare 98.28%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ARNA
51
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.25M 0.3%
21,000
– –
NKTR icon
52
Nektar Therapeutics
NKTR
$626M
$1.2M 0.29%
4,467
– –
ORIC icon
53
Oric Pharmaceuticals
ORIC
$1.02B
$1.1M 0.27%
53,000
– –
EXAS icon
54
Exact Sciences
EXAS
$9.72B
$1.02M 0.25%
10,700
– –
AGIO icon
55
Agios Pharmaceuticals
AGIO
$2.03B
$992K 0.24%
21,500
– –
FOLD icon
56
Amicus Therapeutics
FOLD
$2.44B
$904K 0.22%
94,600
– –
DCPH
57
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$564K 0.14%
16,600
-83,400
-83% -$2.83M
GBT
58
DELISTED
Global Blood Therapeutics, Inc.
GBT
$555K 0.13%
21,800
– –
IMVT icon
59
Immunovant
IMVT
$2.85B
$521K 0.13%
60,000
– –
AXSM icon
60
Axsome Therapeutics
AXSM
$6.09B
$461K 0.11%
14,000
– –
GMDA
61
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$418K 0.1%
107,000
– –
XENE icon
62
Xenon Pharmaceuticals
XENE
$2.96B
$388K 0.09%
25,500
– –
BDTX icon
63
Black Diamond Therapeutics
BDTX
$159M
$371K 0.09%
44,000
– –
ANAB icon
64
AnaptysBio
ANAB
$632M
$271K 0.07%
10,000
– –
RLMD icon
65
Relmada Therapeutics
RLMD
$45.5M
$261K 0.06%
+10,000
New +$261K
BLUE
66
DELISTED
bluebird bio
BLUE
$210K 0.05%
849
– –
FGEN icon
67
FibroGen
FGEN
$47.7M
$201K 0.05%
788
– –
ESPR icon
68
Esperion Therapeutics
ESPR
$488M
$114K 0.03%
9,500
– –
APLS icon
69
Apellis Pharmaceuticals
APLS
$3.5B
– –
-23,400
Closed -$1.48M
ARDX icon
70
Ardelyx
ARDX
$1.54B
– –
-78,000
Closed -$591K
PTGX icon
71
Protagonist Therapeutics
PTGX
$3.61B
– –
-152,000
Closed -$6.81M
ALKS icon
72
Alkermes
ALKS
$4.78B
– –
-45,000
Closed -$1.1M
HALO icon
73
Halozyme
HALO
$8.65B
– –
-82,633
Closed -$3.75M
SRPT icon
74
Sarepta Therapeutics
SRPT
$1.9B
– –
-31,500
Closed -$2.45M
UTHR icon
75
United Therapeutics
UTHR
$17.3B
– –
-43,300
Closed -$7.77M
1 2
3
4